Talk:Peroxisome proliferator-activated receptor

From Wikipedia, the free encyclopedia

Molecular and Cellular Biology WikiProject This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The WikiProject's current monthly collaboration is focused on improving Restriction enzyme.
Stub This article has been rated as Stub-Class on the assessment scale.
Low This article is on a subject of Low-importance within molecular and cellular biology.

Article Grading: The following comments were left by the quality and importance raters: (edit · history · refresh · how to use this template)


It does not appear that this article reads like an encyclopedia article. It is typical of wikipedia articles in the field of biology and chemistry as it is only understandable by someone with the equivalent of a degree in biology or biochem. It is full of jargon and does not discuss the system level impact or effects of the material in the article in a way that a layman can understand. Rather, it reads more like an excerpt from an advanced text or paper from the field.

[edit] human ppar-delta activation

where can i get ppar-delta activating medicaments? —The preceding unsigned comment was added by 84.61.15.154 (talk) 12:50, 31 March 2007 (UTC).

What would you like to achieve with that? JFW | T@lk 21:23, 27 November 2007 (UTC)

[edit] Muraglitazar

We should perhaps quote Steven Nissen's destruction of muraglitazar as an antidiabetic. Obviously, we still know too little about PPAR to predict firmly what modulation will do to bone and coronary artery. JFW | T@lk 21:23, 27 November 2007 (UTC)

RE: Muraglitazar: I presume you mean this? Nissen SE, Wolski K, Topol EJ (2005). "Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus". JAMA 294 (20): 2581–6. doi:10.1001/jama.294.20.joc50147. PMID 16239637.  Boghog2 (talk) 21:47, 27 November 2007 (UTC)
RE: PPAR modulators effect on bone: this looks sobering: Takada I, Suzawa M, Matsumoto K, Kato S (2007). "Suppression of PPAR-γ transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts". Ann N Y Acad Sci. doi:10.1196/annals.1402.034. PMID 17656564.  Boghog2 (talk) 21:47, 27 November 2007 (UTC)